Connect with us

Imovane (zopiclone)

Zopiclone (or IMOVANE®) is mainly prescribed to treat insomnia.

Status: ACTIVE

Class: Nonbenzodiazepine, Z-drug

FDA Approval: 1986

Dosage Forms: 3.75 mg, 5 mg, 7.5 mg

Biological Half-life: 3.5-6.5 hours

Side Effects: Daytime sleepiness, dizziness, anterograde amnesia, lack of coordination, confusion, unpleasant taste, dry mouth, headache, nightmares, hallucinations

Precautions: May cause significantly impaired driving or motor skills

Routes of Administration: Oral

Pregnancy Category: C (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.